Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose cannabidiol crossover study on exercise physiology in healthy endurance-trained adults
ACTRN12620000941965Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol, sponsored by University of Sydney. Primary endpoint: Oxygen utilization during submaximal exercise. Started Aug 2020; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on ACTRN12620000941965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000941965.